Expectations trend
FY2028 · fiscal year ending 2028-09-30 · fmp
$3.51 → $3.48 · observed estimates
Energizer (ENR)
NYSEConsumer StaplesElectrical Equipment & PartsSnapshot 2026-11-04
$24.47-2.86%
Close 2026-11-05 · 1-day change
NYSEConsumer StaplesElectrical Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.51 → 3.48 EPS · FY ending Sep 30, 2028 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ENR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Operating cash flow improves toward historical levels | Operating cash flow improved to $147.8 million in the first half of 2026. | Broken | operating cash flow falls below $120 million next two quarters | Cash from operations: $8.2M FY2026-Q3; GAAP. Published target: >=147.8 million USD. Target period is not explicitly aligned with this observation. Aug 4, 20268,200,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-30 · fmp
$3.51 → $3.48 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ENR is a consumer-staples business with a recovery-oriented multi-year view, supported by robust earnings quality and a favorable sector backdrop. The thesis is intact, although management’s progress on growth and margins is mixed and risk is elevated.
ENR is described as cheap versus peers, while the valuation model also indicates a 0.47 peer premium and a modest expectations gap; these signals are mixed. The pricing assessment is tagged as justified, with low fragility, so the evidence does not point to a highly fragile setup.
Near term, results may remain uneven: organic sales recently improved, but adjusted gross margins have fallen and management lowered its fiscal 2026 outlook to the low end of its stated ranges. Free cash flow progress is mixed, and the next call’s guidance is an important risk; the miss-risk assessment is quiet despite erratic recent earnings surprises and a high-miss-rate industry.
Over the next few quarters, the central test is whether organic growth and margins recover while ENR delivers its reduced earnings outlook and rebuilds cash flow. Continued strength from consumer-staples peers could support the sector backdrop, while weaker jobs data or another guidance cut could increase pressure on the business.
For the 1-to-3-year view, the thesis remains intact, but the recovery is not yet proven and margin, cash-flow, and guidance execution remain key uncertainties. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Management raised 2026 EPS guidance to $3.30-$3.60, aiming for the high end. |
| Under Pressure |
| EPS falls below $3.3 in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross margin near 40% or higher | Energizer is improving profit margins, with gross margin rising to 40.2%. | Broken | gross margin falls below 39% next quarter | Gross margin: 38.22% FY2026-Q3; GAAP. Published target: >=40.0%. Target period is not explicitly aligned with this observation. Aug 4, 202638.223675 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue stabilizes or grows modestly | A supporting condition in Energizer's published investment case. The stated target is >=0% YoY growth. | Improving | revenue declines more than 3% YoY next year | Revenue growth: 1.21% FY2026-Q3; GAAP. Published target: >=0% YoY growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 20261.213291 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.99B → $2.96B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-01 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-02 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-03 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-04 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-05 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-06 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-07 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-08 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-09 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-10 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-11 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-12 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-13 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-14 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-15 | $3.51 | $2,992,571,994 | 2 / 4 |
| 2026-10-16 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-17 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-18 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-19 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-20 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-21 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-22 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-23 | $3.50 | $2,991,708,479 | 2 / 4 |
| 2026-10-24 | $3.48 | $2,961,442,054 | 2 / 4 |
| 2026-10-25 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-26 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-27 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-28 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-29 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-30 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-10-31 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-11-01 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-11-02 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-11-03 | $3.48 | $2,961,433,479 | 2 / 4 |
| 2026-11-04 | $3.48 | $2,961,433,479 | 2 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 2 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 17, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.